Fetroja (Cefiderocol Vials) 1gm

Fetroja (Cefiderocol) 1gm vials are an intravenous antibiotic for adults with complicated urinary tract or kidney infections. This broad-spectrum therapy targets multidrug-resistant gram-negative bacteria. Store at 2–8°C to maintain potency. Always follow healthcare provider guidance when using prescription antibiotics.

Strength

1gm

Pack Size

10s

Storage

2-8°

Manufacturer / TM Owner

Shinogoi Pharma Inc

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fetroja is prescribed to treat complicated urinary tract infections (cUTI), including pyelonephritis, when caused by susceptible gram-negative bacteria. It is also used for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia in adult patients. Healthcare professionals determine suitability based on infection type and bacterial susceptibility.

Side Effects

Patients receiving Fetroja may experience effects such as infusion-site reactions or gastrointestinal discomfort. Some individuals report headache or rash during treatment. These effects vary by person and are typically monitored by a healthcare provider.

Precautions & Warnings

Keep Fetroja vials refrigerated between 2–8°C and protect from light until use. Use only as directed by a licensed healthcare professional. Inform your provider of any allergies, especially to beta-lactam antibiotics, before starting therapy.

Avoid Interactions

Cefiderocol may interact with certain medications, including strong CYP inducers or inhibitors, which can affect antibiotic levels. Concomitant use of other nephrotoxic drugs may increase kidney-related risks. Always disclose all current medications to your healthcare provider.

References

Frequently Asked Questions

Fetroja is an antibiotic used to treat complicated urinary tract infections and hospital-acquired pneumonia caused by susceptible gram-negative bacteria in adults.

Fetroja is given as an intravenous infusion by a healthcare professional, typically over 3 hours every 8 hours.

Yes, Fetroja is prescribed for complicated urinary tract infections, which include kidney infections like pyelonephritis.

Common effects may include infusion-site reactions, headache, rash, or gastrointestinal discomfort.

Yes, Fetroja is a broad-spectrum intravenous antibiotic designed to target multidrug-resistant gram-negative bacteria.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.